Molecule drives aggressive breast cancer

The gene EYA1 was also shown to be overexpressed in a genetic breast cancer subtype called luminal B. The scientists found that excess activity of this gene -- EYA1 -- also enhances development of breast cancer stem cells that promote resistance to cancer therapy, recurrence, and poor survival.

http://www.sciencedaily.com/releases/2013/06/130627190327.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fpharmacology+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Pharmacology%29